Literature DB >> 31217336

Vaccines and global health: In search of a sustainable model for vaccine development and delivery.

Rino Rappuoli1,2, Steven Black3, David E Bloom4.   

Abstract

Most vaccines for diseases in low- and middle-income countries fail to be developed because of weak or absent market incentives. Conquering diseases such as tuberculosis, HIV, malaria, and Ebola, as well as illnesses caused by multidrug-resistant pathogens, requires considerable investment and a new sustainable model of vaccine development involving close collaborations between public and private sectors.
Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31217336     DOI： 10.1126/scitranslmed.aaw2888

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  16 in total

1.  Immunogenicity Evaluating of the Multivalent COVID-19 Inactivated Vaccine against the SARS-CoV-2 Variants.

Authors:  Yuntao Zhang; Wenjie Tan; Zhiyong Lou; Baoying Huang; Weimin Zhou; Yuxiu Zhao; Jin Zhang; Hongyang Liang; Na Li; Xiujuan Zhu; Ling Ding; Yancen Guo; Zhenyu He; Yao He; Zhanhui Wang; Bo Ma; Meng Ma; Suhua Zhao; Zhen Chang; Xue Zhao; Xiaotong Zheng; Guizhen Wu; Hui Wang; Xiaoming Yang
Journal:  Vaccines (Basel)       Date:  2022-06-16

Review 2.  Immunization: vital progress, unfinished agenda.

Authors:  Peter Piot; Heidi J Larson; Katherine L O'Brien; John N'kengasong; Edmond Ng; Samba Sow; Beate Kampmann
Journal:  Nature       Date:  2019-11-06       Impact factor: 49.962

3.  Global vaccine action plan lessons learned I: Recommendations for the next decade.

Authors:  Noni MacDonald; Ezzeddine Mohsni; Yagob Al-Mazrou; Jon Kim Andrus; Narendra Arora; Susan Elden; Marie-Yvette Madrid; Rebecca Martin; Amani Mahmoud Mustafa; Helen Rees; David Salisbury; Qinjian Zhao; Ian Jones; Christoph A Steffen; Joachim Hombach; Katherine L O'Brien; Alejandro Cravioto
Journal:  Vaccine       Date:  2020-05-05       Impact factor: 3.641

4.  Targeted Vaccine Allocation Could Increase the COVID-19 Vaccine Benefits Amidst Its Lack of Availability: A Mathematical Modeling Study in Indonesia.

Authors:  Ahmad Fuady; Nuning Nuraini; Kamal K Sukandar; Bony W Lestari
Journal:  Vaccines (Basel)       Date:  2021-05-06

5.  Vaccine manufacturing capacity in low- and middle-income countries.

Authors:  Mohammed Imran Khan; Aamer Ikram; Hasan Bin Hamza
Journal:  Bull World Health Organ       Date:  2021-07-01       Impact factor: 9.408

Review 6.  Predictive Markers of Immunogenicity and Efficacy for Human Vaccines.

Authors:  Matthieu Van Tilbeurgh; Katia Lemdani; Anne-Sophie Beignon; Catherine Chapon; Nicolas Tchitchek; Lina Cheraitia; Ernesto Marcos Lopez; Quentin Pascal; Roger Le Grand; Pauline Maisonnasse; Caroline Manet
Journal:  Vaccines (Basel)       Date:  2021-06-01

7.  Investigating the Strategies Adopted by Emergency Nurses to Address Uncertainty and Change in the Event of Emerging Infectious Diseases: A Grounded Theory Study.

Authors:  Stanley K K Lam; Enid W Y Kwong; Maria S Y Hung; Wai-Tong Chien
Journal:  Int J Environ Res Public Health       Date:  2020-04-06       Impact factor: 3.390

8.  Confronting Tigecycline-Resistant Acinetobacter baumannii via Immunization Against Conserved Resistance Determinants.

Authors:  Ming-Hsien Chiang; Ya-Sung Yang; Jun-Ren Sun; Yung-Chih Wang; Shu-Chen Kuo; Yi-Tzu Lee; Yi-Ping Chuang; Te-Li Chen
Journal:  Front Microbiol       Date:  2020-03-31       Impact factor: 5.640

9.  Epitope-Based Immunoinformatics Approach on Nucleocapsid Protein of Severe Acute Respiratory Syndrome-Coronavirus-2.

Authors:  Ahmed Rakib; Saad Ahmed Sami; Md Ashiqul Islam; Shahriar Ahmed; Farhana Binta Faiz; Bibi Humayra Khanam; Kay Kay Shain Marma; Maksuda Rahman; Mir Muhammad Nasir Uddin; Firzan Nainu; Talha Bin Emran; Jesus Simal-Gandara
Journal:  Molecules       Date:  2020-11-02       Impact factor: 4.411

Review 10.  Challenges and prospects of COVID-19 vaccine development based on the progress made in SARS and MERS vaccine development.

Authors:  Jubeda Begum; Nasir Akbar Mir; Kapil Dev; Bidyarani Buyamayum; Mohd Yaqoob Wani; Meesam Raza
Journal:  Transbound Emerg Dis       Date:  2020-09-23       Impact factor: 4.521
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.